Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Efficacy of Conivaptan for the Correction of Hyponatremia in Neurological Patients

This study has been withdrawn prior to enrollment.
(Unable to complete a contract with the Sponsor)
Sponsor:
Collaborator:
Astellas Pharma Inc
Information provided by:
Columbia University
ClinicalTrials.gov Identifier:
NCT00684164
First received: May 22, 2008
Last updated: March 5, 2015
Last verified: March 2015
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: June 2010
  Estimated Primary Completion Date: November 2009 (Final data collection date for primary outcome measure)